3/27
08:00 am
vxrt
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
Medium
Report
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
3/20
08:11 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/20
08:00 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/17
11:09 am
vxrt
Estimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT) [Yahoo! Finance]
Medium
Report
Estimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT) [Yahoo! Finance]
3/15
02:04 pm
vxrt
Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/14
04:21 pm
vxrt
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results [Yahoo! Finance]
3/14
04:01 pm
vxrt
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
Low
Report
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
3/7
08:00 am
vxrt
Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14
Medium
Report
Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14
3/6
08:27 am
vxrt
Vaxart Names Steven Lo President, Chief Executive [MarketWatch]
Low
Report
Vaxart Names Steven Lo President, Chief Executive [MarketWatch]
3/6
08:11 am
vxrt
Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director [Yahoo! Finance]
Low
Report
Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director [Yahoo! Finance]
3/6
08:00 am
vxrt
Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director
Low
Report
Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director
2/26
01:54 pm
vxrt
VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
Low
Report
VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
2/20
11:11 am
vxrt
VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy? [Yahoo! Finance]
Low
Report
VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy? [Yahoo! Finance]
2/5
08:12 am
vxrt
Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge [Yahoo! Finance]
Low
Report
Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge [Yahoo! Finance]
2/5
08:00 am
vxrt
Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge
Low
Report
Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge
2/1
06:59 am
vxrt
Strong week for Vaxart (NASDAQ:VXRT) shareholders doesn't alleviate pain of three-year loss [Yahoo! Finance]
Low
Report
Strong week for Vaxart (NASDAQ:VXRT) shareholders doesn't alleviate pain of three-year loss [Yahoo! Finance]
1/31
10:42 am
vxrt
Vaxart, Inc. (NASDAQ: VXRT) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $2.00 price target on the stock.
Neutral
Report
Vaxart, Inc. (NASDAQ: VXRT) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $2.00 price target on the stock.